2005N-0345
  

  
 Drug Approvals:  Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC748
  



  

  
Submitter : 
  

  
Dr. Bridget Bly
  

  
Date & Time: 
  

  
10/13/2005 08:10:17
  



  

  
Organization : 
  

  
Dr. Bridget Bly
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 I am outraged that the FDA has failed to follow the recommendation of its own advisory panel to release the "morning after pill" (Plan B) to consumers.  It's blatant political nonsense, and it makes the FDA look like a pawn of politicians.  Women need this drug, they have a right to it, and to withhold it violates a woman's right to choose.